Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Cross Shawn, Chief Financial Officer. Director active across 3 companies, notably Applied Molecular Transport Inc.. Aggregated, 29 filings have been published. Split: 0 buy · 11 sells. Total volume traded: €576k. History available since 19 August 2021. The latest transaction was filed on 23 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Shawn Cross is the Chief Financial Officer and President & COO of Applied Molecular Transport Inc., a company specializing in developing innovative therapies. In his role, he oversees financial operations and contributes to the company's growth strategy. Shawn Cross plays a crucial role in managing financial resources and optimizing Applied Molecular Transport's economic performance.